CERo Therapeutics Holdings, Inc.
CERO
$0.09
$0.0113.64%
OTC PK
| 09/30/2025 | 06/30/2025 | 03/31/2025 | 12/31/2024 | 09/30/2024 | |
|---|---|---|---|---|---|
| Revenue | -- | -- | -- | -- | -- |
| Total Other Revenue | -- | -- | -- | -- | -- |
| Total Revenue | -- | -- | -- | -- | -- |
| Cost of Revenue | 500.00K | -- | -- | -- | -- |
| Gross Profit | -500.00K | -- | -- | -- | -- |
| SG&A Expenses | 9.64M | 10.29M | 10.05M | 10.73M | 9.62M |
| Depreciation & Amortization | -- | -- | -- | -- | -- |
| Other Operating Expenses | -- | -- | -- | -- | -- |
| Total Operating Expenses | 17.50M | 17.04M | 16.75M | 16.20M | 15.22M |
| Operating Income | -17.50M | -17.04M | -16.75M | -16.20M | -15.22M |
| Income Before Tax | -14.71M | -14.08M | -11.11M | -8.30M | -10.24M |
| Income Tax Expenses | -- | -- | -- | -- | -- |
| Earnings from Continuing Operations | -14.71 | -14.08 | -11.11 | -8.30 | -10.24 |
| Earnings from Discontinued Operations | -- | -- | -- | -- | -- |
| Extraordinary Item & Accounting Change | -- | -- | -- | -- | -- |
| Minority Interest in Earnings | -- | -- | -- | -- | -- |
| Net Income | -14.71M | -14.08M | -11.11M | -8.30M | -10.24M |
| EBIT | -17.50M | -17.04M | -16.75M | -16.20M | -15.22M |
| EBITDA | -17.18M | -16.68M | -16.35M | -15.76M | -14.77M |
| EPS Basic | -139.93 | -301.05 | -303.13 | -333.50 | -297.79 |
| Normalized Basic EPS | -57.06 | -161.05 | -154.11 | -176.88 | -148.71 |
| EPS Diluted | -139.93 | -301.05 | -303.13 | -333.50 | -297.79 |
| Normalized Diluted EPS | -57.06 | -161.05 | -154.11 | -176.88 | -148.71 |
| Average Basic Shares Outstanding | 6.66M | 5.42M | 4.93M | 1.37M | 62.70K |
| Average Diluted Shares Outstanding | 6.66M | 5.42M | 4.97M | 1.41M | 100.60K |
| Dividend Per Share | -- | -- | -- | -- | -- |
| Payout Ratio | -- | -- | -- | -- | -- |